Draft study says thousands of adverse events are linked to Avandia

06/10/2010 | Wall Street Journal, The

An unpublished study conducted by an FDA scientist linked GlaxoSmithKline's diabetes drug Avandia to up to 48,000 heart attacks, strokes and other problems in Medicare patients between 1999 and 2009. The research will be included in the FDA's safety review of Avandia in mid-July, an agency official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD